G&E Herbal Biotechnology CoROCO:4911 +0.80%63 OCF Margin % is 27.61% as of Dec. 2025, which is 134% above its 10-year median of 11.82. GuruFocus rates ROCO:4911 with a GF Score™ of 63/100 and a GF Value™ of NT$86.06 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 959 Biotechnology companies, G&E Herbal Biotechnology Co ranks better than 85.71% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4911 vs VRTX, REGN, ALNY: OCF Margin % Comparison
For the Biotechnology subindustry, G&E Herbal Biotechnology Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
G&E Herbal Biotechnology Co OCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, G&E Herbal Biotechnology Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where G&E Herbal Biotechnology Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
G&E Herbal Biotechnology Co (ROCO:4911) has a OCF Margin % of 27.61% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on G&E Herbal Biotechnology Co and its competitors. This is 134% above median its historical median of 11.82. According to the industry distribution chart, G&E Herbal Biotechnology Co ranks #137 out of 959 companies in the Biotechnology industry, placing it in the top 14.3%.
Is G&E Herbal Biotechnology Co's OCF Margin % too high?
G&E Herbal Biotechnology Co's current OCF Margin % of 27.61% is 134% above median its 10-year median of 11.82. Based on the distribution chart, G&E Herbal Biotechnology Co ranks #137 out of 959 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, G&E Herbal Biotechnology Co has a GF Score™ of 63/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does G&E Herbal Biotechnology Co's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, G&E Herbal Biotechnology Co ranks #137 out of 959 companies for OCF Margin %. This places G&E Herbal Biotechnology Co in the top 14% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on G&E Herbal Biotechnology Co and its competitors. G&E Herbal Biotechnology Co's current OCF Margin % is 27.61%, which is 134% above median its own 10-year median of 11.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is G&E Herbal Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, G&E Herbal Biotechnology Co (ROCO:4911) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$86.06, compared to a current price of NT$31.35 — trading 63.6% below its estimated fair value. The current OCF Margin % is 27.61%, which is 134% above median its 10-year median of 11.82. G&E Herbal Biotechnology Co's overall GF Score™ is 63/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For G&E Herbal Biotechnology Co (ROCO:4911), the current OCF Margin % is 27.61% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is G&E Herbal Biotechnology Co (ROCO:4911) Overvalued in 2026?
Based on GuruFocus' analysis, G&E Herbal Biotechnology Co stock appears to be undervalued.
The current stock price of NT$31.35 is trading 63.6% below its estimated GF Value™ of NT$86.06.
GuruFocus considers G&E Herbal Biotechnology Co to be Significantly Undervalued.
Key valuation signals for ROCO:4911:
OCF Margin %: 27.61% (134% above median its 10-year median of 11.82)
GF Value™: NT$86.06 vs. price of NT$31.35 (63.6% below fair value)
No single metric tells the full story. See the ROCO:4911 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
G&E Herbal Biotechnology Co Ltd is a Taiwan-based biopharmaceutical company. It specializes in the production of Western conventional drugs, Chinese traditional drugs, unclassified food, cosmetics, and health products. The company is focused on botanical extraction technology and products. Its products include botanical extract toner, total moisture conditioning cream, whitening clear cream, and firming essence cream.
63GF Score
Get the complete analysis for ROCO:4911
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4911 has been successfully added to your 
